Ultrawide-field indocyanine angiography changes post 12 weeks of eplerenone in central serous chorioretinopathy
Aketi Sagar, Sanjay Mishra, Pradeep Kumar, Alok Sati, Ashutosh Gupta, Abhijeet Avasthi, D Srujana, Supriya Dhar, M Khaleel, Amrita Joshi · 2026
Read Ultrawide-field indocyanine angiography changes post 12 weeks of eplerenone in central serous chorioretinopathy by Aketi Sagar, Sanjay Mishra, Pradeep Kumar, Alok Sati, Ashutosh Gupta, Abhijeet Avasthi, D Srujana, Supriya Dhar, M Khaleel, Amrita Joshi (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13271547.txt.
Description
Aketi Sagar and colleagues report in 2026 on eye imaging changes after three months of eplerenone treatment for central serous chorioretinopathy. In this condition, fluid leaks under the retina because the choroid layer below becomes overly permeable. Eplerenone blocks a hormone receptor thought to drive that leakage.
Fifty-eight adults took the drug daily while the team tracked wide-field angiography, retinal scans, and vision over twelve weeks. The main measure was change in the total area of choroidal leakage on the angiogram images. Linking those wide views to vision and anatomy results may show whether the drug calms leakage across the whole choroid, not just at the center.
Catalog record
| CREATOR | Aketi Sagar, Sanjay Mishra, Pradeep Kumar, Alok Sati, Ashutosh Gupta, Abhijeet Avasthi, D Srujana, Supriya Dhar, M Khaleel, Amrita Joshi |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 31 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |